Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP662415.RAvhz-9OKZsaSBK2fYilMWCjvJ6U-ZKpV02DjCfGBnMaU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP662415.RAvhz-9OKZsaSBK2fYilMWCjvJ6U-ZKpV02DjCfGBnMaU130_assertion type Assertion NP662415.RAvhz-9OKZsaSBK2fYilMWCjvJ6U-ZKpV02DjCfGBnMaU130_head.
- NP662415.RAvhz-9OKZsaSBK2fYilMWCjvJ6U-ZKpV02DjCfGBnMaU130_assertion description "[The laboratory investigations performed for the assessment of thrombophilia included protein C, protein S, antithrombin III deficiencies, activated protein C resistance, factor V Leiden (FVL), prothrombin 20210A (PT 20210) and methylenetetrahydrofolate reductase (MTHFR) gene mutations, factor VIII elevation, lupus anticoagulant and antiphospholipid antibodies (APA).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP662415.RAvhz-9OKZsaSBK2fYilMWCjvJ6U-ZKpV02DjCfGBnMaU130_provenance.
- NP662415.RAvhz-9OKZsaSBK2fYilMWCjvJ6U-ZKpV02DjCfGBnMaU130_assertion evidence source_evidence_literature NP662415.RAvhz-9OKZsaSBK2fYilMWCjvJ6U-ZKpV02DjCfGBnMaU130_provenance.
- NP662415.RAvhz-9OKZsaSBK2fYilMWCjvJ6U-ZKpV02DjCfGBnMaU130_assertion SIO_000772 19937485 NP662415.RAvhz-9OKZsaSBK2fYilMWCjvJ6U-ZKpV02DjCfGBnMaU130_provenance.
- NP662415.RAvhz-9OKZsaSBK2fYilMWCjvJ6U-ZKpV02DjCfGBnMaU130_assertion wasDerivedFrom befree-20140225 NP662415.RAvhz-9OKZsaSBK2fYilMWCjvJ6U-ZKpV02DjCfGBnMaU130_provenance.
- NP662415.RAvhz-9OKZsaSBK2fYilMWCjvJ6U-ZKpV02DjCfGBnMaU130_assertion wasGeneratedBy ECO_0000203 NP662415.RAvhz-9OKZsaSBK2fYilMWCjvJ6U-ZKpV02DjCfGBnMaU130_provenance.